- Home
- XRN vs ANGO Comparison
XRN vs ANGO Comparison
Compare XRN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRN | ANGO |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.5M | 420.2M |
| IPO Year | 2016 | 2004 |
Fundamental Metrics
Financial Performance| Metric | XRN | ANGO |
|---|---|---|
| Price | $37.04 | $12.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 145.8K | ★ 273.5K |
| Earning Date | 05-06-2026 | 04-02-2026 |
| Dividend Yield | ★ 8.56% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $4.50 | $9.51 |
| Revenue Next Year | $3.83 | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $29.05 | $8.36 |
| 52 Week High | $37.95 | $13.99 |
Technical Indicators
Market Signals| Indicator | XRN | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 59.63 |
| Support Level | $34.68 | $10.45 |
| Resistance Level | $37.95 | $12.72 |
| Average True Range (ATR) | 0.94 | 0.40 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 72.41 | 74.85 |
Price Performance
Historical ComparisonAbout XRN Chiron Real Estate Inc. Common Stock
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.